{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T05:16:05Z","timestamp":1767071765381,"version":"3.48.0"},"reference-count":22,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T00:00:00Z","timestamp":1766880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Antimicrobial resistance is an escalating public health threat. Despite the low prevalence of community-acquired bacterial coinfection (CABC) in patients presenting with COVID-19, antibiotics are frequently prescribed. We evaluated antibiotic prescribing for suspected CABC in adults admitted with COVID-19 to a metropolitan referral hospital in South Australia and the impact of a targeted, locally developed educational intervention. Methods: We conducted a closed-loop retrospective audit of consecutive adult COVID-19 non-intensive care unit admissions to the General Medicine Unit over a six-month period (5 February\u20136 August 2024), totalling 126 episodes after exclusions. Antibiotic prescribing rates were compared before and after implementation of targeted education to admitting clinicians. This was delivered via guideline-focused presentations at unit meetings, emails and posters in key clinical areas detailing the consensus recommendation, and brief electronic reminder messages. Prescribing appropriateness was inferred from adherence to the consensus recommendation, which included predefined criteria relating to total leukocyte count, neutrophilia, and radiological findings. Statistical comparisons were performed using appropriate statistical tests for categorical and continuous variables. Results: Following the intervention, antibiotic prescribing decreased from 26% to 22% of admissions (p = 0.57), and prescribing among patients who did not meet the specified criteria fell from 16% to 6% (p = 0.30). The proportion of prescriptions meeting the consensus criteria increased from 62% to 80% (p = 0.43). Conclusions: Baseline antibiotic use was substantially lower than commonly published rates but still exceeded expected CABC prevalence. Targeted education and simple, locally adaptable guidance may support improved antimicrobial stewardship in COVID-19 admissions.<\/jats:p>","DOI":"10.3390\/jcm15010239","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:50:42Z","timestamp":1766969442000},"page":"239","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibiotic Prescribing in Patients Presenting with COVID-19: A Closed-Loop Audit with a Targeted Educational Intervention in a South Australian Hospital"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6425-6169","authenticated-orcid":false,"given":"Robert","family":"Yarham","sequence":"first","affiliation":[{"name":"Department of Health and Medical Sciences, University of Adelaide, Corner of George Street and North Terrace, Adelaide, SA 5000, Australia"},{"name":"General Medicine Department, Royal Adelaide Hospital, Port Road, Adelaide, SA 5000, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3319-1037","authenticated-orcid":false,"given":"Colette","family":"Dignam","sequence":"additional","affiliation":[{"name":"Department of Health and Medical Sciences, University of Adelaide, Corner of George Street and North Terrace, Adelaide, SA 5000, Australia"},{"name":"General Medicine Department, Royal Adelaide Hospital, Port Road, Adelaide, SA 5000, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5487-9992","authenticated-orcid":false,"given":"Dylan","family":"Toh","sequence":"additional","affiliation":[{"name":"General Medicine Department, Royal Adelaide Hospital, Port Road, Adelaide, SA 5000, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,28]]},"reference":[{"key":"ref_1","unstructured":"World Health Organisation (2019). No Time to Wait: Securing the Future from Drug-Resistant Infections, World Health Organisation."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Najafi-Olya, Z., Heydarifard, Z., Looha, M.A., Ahmadi, A.S., Yarhamadi, N., and Safaei, M. (2025). Antibiotic resistance and bacterial co-infections in COVID-19 patients in Iran: A systematic review and meta-analysis of hospitalized and non-hospitalized cases. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-11643-6"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.jiph.2021.10.020","article-title":"Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects","volume":"14","author":"Uddin","year":"2021","journal-title":"J. Infect. Public Health"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Bell, B.G., Schellevis, F., Stobberingh, E., Goossens, H., and Pringle, M. (2014). A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-13"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis","volume":"26","author":"Langford","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","article-title":"Bacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing","volume":"71","author":"Rawson","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Jiang, L., Jin, Y., Li, J., Zhang, R., Zhang, Y., Cheng, H., Lu, B., Zheng, J., Li, L., and Wang, Z. (2024). Respiratory pathogen coinfection during intersecting COVID-19 and influenza epidemics. Pathogens, 13.","DOI":"10.3390\/pathogens13121113"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijid.2022.03.003","article-title":"Bacterial co-infection at hospital admission in patients with COVID-19","volume":"118","author":"Letona","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e533","DOI":"10.1093\/cid\/ciaa1239","article-title":"Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with coronavirus disease 2019 (COVID-19): A multi-hospital cohort study","volume":"72","author":"Vaughn","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hedberg, P., Johansson, N., Ternhag, A., Abdel-Halim, L., Hedlund, J., and Naucl\u00e9r, P. (2022). Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-022-07089-9"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e13107","DOI":"10.1111\/irv.13107","article-title":"Bacterial and viral infections among adults hospitalized with COVID-19, COVID-NET, 14 states, March 2020\u2013April 2022","volume":"17","author":"Shah","year":"2023","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e15265","DOI":"10.7717\/peerj.15265","article-title":"Bacterial coinfection and antibiotic resistance in hospitalized COVID-19 patients: A systematic review and meta-analysis","volume":"11","author":"Norhayati","year":"2023","journal-title":"PeerJ"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Musuuza, J.S., Watson, L., Parmasad, V., Putman-Buehler, N., Christensen, L., and Safdar, N. (2021). Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0251170"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e24151","DOI":"10.1002\/jcla.24151","article-title":"Worldwide prevalence of microbial agents\u2019 coinfection among COVID-19 patients: A comprehensive updated systematic review and meta-analysis","volume":"36","author":"Pakzad","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/imj.15631","article-title":"Risk factors and early prediction of clinical deterioration and mortality in adult COVID-19 inpatients: An Australian tertiary hospital experience","volume":"52","author":"Brook","year":"2022","journal-title":"Intern. Med. J."},{"key":"ref_16","unstructured":"World Health Organisation (2025). Clinical Management of COVID-19: Living Guideline, June 2025, World Health Organisation."},{"key":"ref_17","unstructured":"National Institute for Health and Care Excellence (NICE) (2021). COVID-19 Rapid Guideline: Managing COVID-19. 6. Identifying and Managing Co-Infections, National Institute for Health and Care Excellence (NICE)."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jmii.2022.12.003","article-title":"Recommendations and guidelines for the diagnosis and management of coronavirus disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan","volume":"56","author":"Wu","year":"2023","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1017\/ash.2024.372","article-title":"Are C-reactive protein and procalcitonin safe and useful for antimicrobial stewardship purposes in patients with COVID-19? A scoping review","volume":"4","author":"Williams","year":"2024","journal-title":"Antimicrob. Steward. Healthc. Epidemiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.2147\/JIR.S377644","article-title":"Procalcitonin as a tool to antimicrobial stewardship in COVID-19 patients with superimposed bacterial infections: A systematic review","volume":"15","author":"Omer","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e70105","DOI":"10.1002\/iid3.70105","article-title":"Blood inflammatory markers and cytokines in COVID-19 patients with bacterial coinfections","volume":"12","author":"Bi","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41479-020-00074-3","article-title":"Etiology of community-acquired pneumonia in adults: A systematic review","volume":"12","author":"Shoar","year":"2020","journal-title":"Pneumonia"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/239\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T05:12:19Z","timestamp":1767071539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,28]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15010239"],"URL":"https:\/\/doi.org\/10.3390\/jcm15010239","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2025,12,28]]}}}